Agoracom Blog Home

Posts Tagged ‘#smallcapstocks’

INTERVIEW: betterU (BTRU:TSX-V) $30 Million Marketing Plan Reaches 100 Million Potential Customers Every Week $BTRU.ca

Posted by AGORACOM-JC at 8:51 AM on Wednesday, April 19th, 2017

Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec $TBP.ca

Posted by AGORACOM-JC at 8:45 AM on Wednesday, April 19th, 2017

Tbp large

  • Announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec
  • Enter into a joint supply agreement, with Aphria supplying dried medical cannabis under its ACMPR license, and Tetra packaging the product using the manufacturing process developed for its in-progress clinical drug trial for PPP001

OTTAWA, ONTARIO–(April 19, 2017) - Tetra Bio-Pharma Inc. (“Tetra”) (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) and Aphria Inc. (“Aphria”) (TSX:APH) (OTCQB:APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.

Tetra and Aphria will enter into a joint supply agreement, with Aphria supplying dried medical cannabis under its ACMPR license, and Tetra packaging the product using the manufacturing process developed for its in-progress clinical drug trial for PPP001. The formulation and packaging will be completed by Tetra, under its CDSA dealer’s licence, at its New Brunswick facility. Based on the success of the venture, Tetra and Aphria may expand into other provinces. The venture is preparing to initiate its commercial operations early summer 2017 with revenues commencing in Tetra’s third quarter of 2017 and Aphria’s first quarter of 2018.

“This commercial venture is an important decision for Tetra shareholders as it will start generating revenues this summer which will be invested back into developing PPP001 as a prescription pharmaceutical,” said Andre Rancourt, CEO of Tetra Bio-Pharma Inc. “Tetra will be accelerating its manufacturing and quality studies as required by the U.S. and Canadian prescription drug and controlled substance regulations. The investment in this research will be offset by sales revenues generated under the ACMPR.”

“The commercial venture between Tetra and Aphria will enhance Aphria’s brand visibility and distribution of our high-quality medical grade cannabis into the maritime provinces and Quebec, as we look to meet the commercial demand for PPP001,” said Vic Neufeld, CEO of Aphria Inc. “As a leading Canadian licensed producer, it was important for us to work with an organization that shares our focus on pharmaceutical-grade quality assurance and control. Tetra’s emphasis on developing products driven by patient needs and scientific research and development makes them the perfect partner in this important next step for Aphria.”

Tetra and Aphria have invested in the development of its PPP001 drug and will continue to invest to bring PPP001 to market in both Canada and USA as the first prescription drug using dried cannabis. The corporations have developed a high quality dried cannabis product and would like to make it available to physicians under the current ACMPR program. The quality and clinical research studies completed to date would be integrated into a joint Continuing Medical Education program for physicians and pharmacists. Tetra and Aphria have concluded that there is demand for an evidence-based approach in medical cannabis and the two companies intend on using their pharmaceutical approach to help patients. The venture will also be commercializing devices for the inhalation of medical cannabis.

About Tetra Bio-Pharma:

Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

About Aphria:

Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licenced producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters. For more information, visit www.Aphria.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements – Tetra Bio-Pharma Inc.

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Forward-looking statements – Aphria Inc.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS – APHRIA: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations related to the completion of this project, its revenue and gross margin expectations, expectations for future growing capacity and costs, the completion of any capital project or expansions, any commentary related to the legalization of marijuana and the timing related thereto, expectations of Health Canada approvals and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
edward@tetrabiopharma.com
(343) 689-0714

Aphria Inc.
Nina Godard
Edelman
nina.godard@edelman.com
416-455-6324

Aphria Inc.
Vic Neufeld
President & CEO
1-844-427-4742

Durango Completes Acquisition of Windfall Lake $DGO.ca

Posted by AGORACOM-JC at 8:25 AM on Tuesday, April 18th, 2017

Logo

  • Windfall Lake Gold Camp area (the “Windfall East Property” and “Windfall West Property”, and collectively the “New Windfall Properties”) has been approved by the TSX Venture Exchange.
  • Durango closed the acquisition on April 11, 2017

Vancouver, BC / April 18, 2017 – Durango Resources Inc. (TSX.V-DGO) (Frankfurt-86A1) (OTC-ATOXF), (the “Company” or “Durango”) announces that further to its news release dated March 6, 2017, its recent acquisition of properties in the Windfall Lake Gold Camp area (the “Windfall East Property” and “Windfall West Property”, and collectively the “New Windfall Properties”) has been approved by the TSX Venture Exchange. Durango closed the acquisition on April 11, 2017.

The New Windfall Properties are comprised of approximately 2,700 hectares and adjoin the limit of Osisko Mining Inc.’s (TSX-OSK) property. The Windfall East Property is approximately five kilometres southeast of the Black Dog Au-Ag-Cu discovery. Osisko is currently drilling the extent of this new mineralization which appears as distinct subvertical zones dipping to the southeast and distributed along a NE-trending linear magnetic structure (Osisko’s Press release of January 18, 2017 and conceptual model on Osisko’s website).

The Windfall East Property runs along the southern perimeter of a projected large fault/lineament, a favorable environment for Archean lode gold deposit. Although the Windfall East Property is located outside the mapped Urban Barry greenstone belt, it remains prospective as many gold occurrences are found outside greenstone belts (eg. Cheechoo Project of Sirios Resources) and are rather driven by structural controls.

A limited amount of exploration work has been conducted over the Windfall East Property which totals an area of over 2,000 hectares. It is located within 1.5 km of the regional northeast-southwest faults extending from the Gladiator project of Bonterra Resources. A power line is crossing the central portion of the east claim block, and several lakes and rivers are present, which may facilitate access for future exploration work. Topography indicates that the area could be suitable for a till survey, as a first step to outline future targets.

The Windfall West Property is an additional block of approximately 675 hectares and is located to the west of Durango’s Trove property and adjoins Beaufield Resources Inc.’s (TSX.V-BFD) western perimeter and is accessible for exploration work via a main logging road from the town of Lebel-sur-Quevillon.

Marcy Kiesman CEO of Durango stated, “Durango is reviewing several exploration programs which could be initiated to advance the New Windfall Properties. Durango is confident in the prospective gold acquisitions in the Windfall area and looks forward to the exploration year ahead.”

The technical contents of this release were approved by Mrs. Isabelle Robillard, M.Sc., P.Geo., an associate of Inlandsis Consultants s.e.n.c who is a Qualified Person as defined by National Instrument 43-101.

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and the NMX East lithium property near the Whabouchi mine and the Buckshot graphite property near the Miller Mine in Quebec, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: durangoresourcesinc@gmail.com

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including, but not limited to the exploration of the New Windfall Properties, the entering into of any transaction and/or financing with any third parties and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Mining Minute – 2.12- Infrastructure Funds Application Submitted Yet? $KWG.ca

Posted by AGORACOM-JC at 5:22 PM on Thursday, April 13th, 2017

The marijuana market could be (and possibly already is) bigger than the market for beer in Canada $TBP.ca $N.ca

Posted by AGORACOM-JC at 5:20 PM on Thursday, April 13th, 2017

The marijuana market could be (and possibly already is) bigger than the market for beer in Canada

Pot’s retail therapy

TORONTO — It’s a hot, sunny Thursday afternoon on the hard edge of Queen Street West, and the foot traffic at Eden, a pot dispensary, is brisk.

Retailers along this strip of trendy clothing stores, bars, restaurants, shoe shops, tattoo parlours, hairstylists, comic stores and coffee joints cater to the urban hip, and Eden is no different. lnside, iceberg-blue lights illuminate jewel-case cabinets with the product — glass vials of Hindu Kush, El Hefe, Organic Blue Dream — artfully displayed.

On the aquamarine-blue wall at the front are two white iPads, for customers who need quick access to the Internet to check product information.

The place is spotless, sharp. And the air is heavy with the unmistakeable sweet smell of cannabis.

Pot store
The fridge at Eden Medicinal Society, a cannabis retailer in Toronto. (Tyler Anderson / National Post)

Behind the counter, two clerks, a man and a woman both in their 20s, both dressed like their customers, are filling orders, taking cash.

The average transaction, those in the business say, is $50. A pre-rolled joint is $12, but Alicia, the manager, says they won’t start selling a lot of those until the evening, when the university crowd and the kids from the suburbs come downtown.

The afternoonwalk-ins are largely cannabis users who rely on the flowers, ointments, teas, and oils to ease some chronic ailment, or they are creative types — writers, graphics artists, filmmakers — who find extra insight and energy through cannabinoid stimulation. They all have prescriptions from a licensed physician.

The product mix and retail approach at Eden’s downtown store is different than what you will find at the company’s newest outlet a few blocks north near Bayview and Eglinton. There are more seniors and aging baby boomers in that neighbourhood so the store opens earlier and closes earlier.

The Eden outlets are among the 100 or so pot dispensaries in Toronto, but there is easily demand, those in the industry say, for 1,000 such businesses.

They are owned and operated by a mix of campaigners and capitalists.


The campaigners have been working for years to legalize marijuana use. They believe in the huge potential for the drug to manage pain, ease anxiety, and help many to a more productive, happy, creative and healthy existence.

Tania Cyalume and Brandy Zurborg opened their storefront dispensary, Queens of Cannabis, on Bloor Street West just north of Little Italy in February.

Queens of Cannabis owners Tania Cyalume and Brandy Zurborg outside their shop in May 2016. (Maryam Shah / Postmedia Network)

“I guess when you believe in a product, you really believe in it because you’ve seen the way that it affects people,” said Cyalume.

The products Cyalume and Zurborg sell and their approach to retailing match their personal philosophies and lifestyles. Both are vegans, and the edible cannabis products they stock are vegan and  pesticide-free.

Their crusade is about serving patients because they are patients themselves, and use cannabis products regularly to treat their own chronic pain and ailments.

“We’re patients and we believe in it. We also believe that patients have the first right to access before recreational. There is only so much supply, and there is a huge demand,” said Zurborg, who trained as a certified management accountant designation and was  an auditor with the Canada Revenue Agency.

Their goal is not necessarily to get rich. They speak of one day being able to use the proceeds of their retail operation to help fund outreach, at hospices for example, where they can spread the word about the life-changing value of cannabis products.

Marina, who preferred her last name not be used, is a capitalist. She and her husband have had as many as seven dispensaries, some through a franchise model they were trying to build. When she got into the business a few years ago, she approached with a capitalist’s zeal and eye for profit.

The woman has agreed to talk about her industry at an upscale diner set among the forest of steel-and-glass condominium towers where Lake Ontario meets the Toronto suburb of Etobicoke. She arrived in a gleaming white SUV. Petite, direct and energetic, Marina makes no bones about the fact she got into the business to make a pile of cash.

- See more at: http://news.nationalpost.com/features/o-cannabis-retail-therapy#sthash.q9qC3FZy.dpuf

AGORACOM Welcomes BetterU Education Corp. (TSX-V:BTRU) with $30M marketing investment deal signed, ability to reach 100M potential learners each week $BTRU.ca

Posted by AGORACOM-JC at 4:50 PM on Wednesday, April 12th, 2017

Betteru large

CONNECTING GLOBAL EDUCATION WITH THE INDIAN MARKETPLACE

WHY BETTERU EDUCATION?

  • Partnering with leading content providers from around the world
  • Promoting / managing quality online education in India
  • Marketplace’ has been designed to represent our educators programs

TIMES OF INDIA PARTNERSHIP

  • betterU signed a 150 Crore (approx $30 million) marketing investment deal with Bennett Coleman Company Ltd. (Times Group)
  • Provides betterU with significant market visibility
  • Enables betterU to be promoted across upwards of 80% of the country by means of newsprint, radio, digital, TV, OHH and Medianet
  • Bringing awareness to marketplace, education partners’ programs to the mass population of the country on a weekly basis.

THE MODEL

  • Provides mass marketing across India (Newsprint, Radio, TV, Digital, and Magazine),
  • Collects all registrations and payments, then through back end coding, connect the learner to the content partner’s course
  • Holds back 20% to 50% of revenues collected as their fee

WHY INDIA

  • Indian Government has mandated to educate and skill up 500 million people by 2022
  • Focused on digitizing the country
  • National Skills Development Corporation has a directive to educate and skill up 150 million people in India
  • Online education is the only way these mandates can be accomplished
  • India is expecting to double in online education sales from $20B to $40B this year.

Investment Highlights

Market: Access to ‘high-barrier to entry’ Indian market through current Indian operations.

First Mover: Potential to become leading “global education marketplace” in India.

Developed Product: GENERATING REVENUE!

Unmatched Variety: Over 6,500 courses available.

Wide Audience: K-12, exam preparation, skills development, higher-ed and more.

Product Expansion Opportunities: B2B, B2C learning and employment solutions.

INFRUSTRUCTURE 

  • Established an Indian entity in order to effectively do business in India
  • Ability to collect from 200 different payment methods in India
  • People on the ground in India
  • Established strong relationships with institutions, training partners and leaders across multiple sectors.

STOCK CHART

Tetra Bio-Pharma Announces Opening of a New Brunswick Office for Manufacturing & Sales Activities $TBP.ca

Posted by AGORACOM-JC at 4:46 PM on Wednesday, April 12th, 2017

Tbp large

  • Announced today it has opened an office in Moncton, New Brunswick for its manufacturing and sales activities
  • New Brunswick becoming the hub for the Canadian Cannabis industry

OTTAWA, ONTARIO–(April 12, 2017) - Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF) announced today it has opened an office in Moncton, New Brunswick for its manufacturing and sales activities. New Brunswick is becoming the hub for the Canadian Cannabis industry.

Tetra is preparing to commercialize several retail products later this year with expected revenues to be generated for the corporation in the fourth quarter. Tetra has already initiated the process to manufacture the first products that act on the cannabinoid system that will be commercialized later this year for sale in Canada and the USA. The Company also intends on commercializing devices (e.g., pipes) for the consumption of medical marijuana in 2017. The Tetra office in Moncton will be responsible to oversee the timely production and launch of the products as well as adhering to the corporation’s budgets.

Tetra has initiated its Phase I clinical trial in March 2017 after manufacturing the PPP001 cannabis drug product at the Ford Pharma contract manufacturing facility in Moncton, New Brunswick. This contract facility developed the proprietary process and equipment required to produce PPP001 pellets and packaging operations. Tetra is also using the contract services of RPC, a New Brunswick provincial crown corporation, to perform its quality control studies to assure that PPP001 conforms to its drug product specifications and quality requirements of a prescription drug.

“We are pleased to announce the opening of a new office in New Brunswick which has become one of the leading provinces in Canada to support the cannabis industry,” said Andre Rancourt, CEO of Tetra Bio-Pharma Inc. “Tetra will manufacture our PPP001 prescription drug as well as additional scheduled products later this year. We are advancing our projects forward which are on time and on budget, a key priority for the Tetra team. We are now one-step closer towards our goal of commercialization in bringing our innovative cannabis based products to market.”

“We acted quickly to prepare for the development of this industry in New Brunswick,” said Stephen Lund, CEO of Opportunities NB. “The addition of Tetra Bio-Pharma to the province is welcomed news. We have the research, education and production facilities in place for companies to be successful in this rapidly growing industry.”

According to Dr. Guy Chamberland, CSO at Tetra Bio-Pharma Inc., “The use of the facility in Moncton allows Tetra to manufacture the PPP001 drug product for the clinical trial according to the corporation’s timelines and budget. The RPC research and technology organization provides Tetra with the high-level expertise required for assessing the quality aspects of PPP001 while keeping the costs associated with these activities within budget due to RPC not-for-profit status. I can report that the Phase 1 trial is advancing on schedule and according to the corporation’s plans we expect to complete the Phase Ia portion of the study by mid-May. The results of the Phase Ia will provide TBP with a strategic understanding of the commercial potential of marijuana products and allow the corporation to complete its Phase II and III trial plans.”

About Tetra Bio Pharma:
Tetra Bio Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(OTCQX:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
edward@tetrabiopharma.com
(343) 689-0714

FEATURE: AIM Exploration (AEXE: OTC) Exploring Anthracite Coal, The Highest Quality Metallurgical Coal Available $AEXE.us

Posted by AGORACOM-JC at 10:35 AM on Wednesday, April 12th, 2017

  • Coal is the world’s largest source of energy for the production of electricity.
  • 1 billion tons of coal used in global industrial steel production each year.
  • There are zero alternatives to coal in the industrial steel-making process.

Anthracite Coal

What Is It and Why This Is So Important?

Anthracite is officially classified as coal however it is not just another fuel, anthracite should not be confused with just ordinary bituminous coal.

Anthracite is the highest quality metallurgical coal available, clean burning, hard coal with the highest carbon content of any coal, very energy efficient and even burns smoke free.

This premium coal represents only 1% of world coal reserves.

The Cleanest Burning Solid Fossil Fuel

Anthracite is an almost pure form of carbon. It has a very high heat value, and very low levels of sulphur and other impurities. This makes it not only the most sought after home heating fuel but also a much sought after, high quality component for a number of industries.

The anthracite coal extracted from the AIM coal concessions in Peru have been tested by the world-wide highly regarded SGS labs and the findings indicate a very high fixed carbon, very low ash and sulpher content with a high calorific value.

AIM would be pleased to provide the analysis upon request.

Why Does the World Need Anthracite Coal?

As a result of its attributes, anthracite coal trades at prices substantially higher than thermal coal and has a lower environmental impact. High quality anthracite is increasingly sought for by the steel industry, always under pressure to reduce costs and improve margins.

Metallurgical coal together with iron ore is the principal raw materials used to make steel. As such, it supports an improved quality of life for all of us through its use in the construction of homes and hospitals, and in the production of everything from mass transportation vehicles to wind turbines.

Due to its high carbon content and low volatiles, anthracite is more reactive and efficient with respect to energy released than the lower–ranked coals and consequently has a lower environmental impact due to the lower greenhouse gas emissions.

The industry most commonly associated with anthracite is the steel industry.

Within the steelmaking industry, anthracite is used in three processes

  1. Pulverized coal injection
  2. Basic Oxygen Steel
  3. Electric Arc Furnaces

Present Activities

  • Anthracite Samples from AIM's PropertyAssets encompass 1,000 hectares of mining concession property consisting of three sites of 600, 200 and 200 hectares respectively.
  • Percana SA initially acquired these properties based on indications of the presence of high grade anthracite coal. Illegal artisan miners are currently operating multiple one-entry mines on the property, which further indicates the presence and mine-ability of these deposits.
  • To verify the geology and quality of the coal, Percana SA commissioned local geologists to compile a technical report on the 1,000 hectares. Although the report yielded optimistic estimates of resources, reserves and economics, it does not meet public reporting standards.

LOCATION

  • located in Huaranchal, which is one of ten districts in the province of Otuzco.
  • Two-hour drive from Trujillo (the second largest city in Peru), and an equal distance to the city of Otuzco.
  • Also strategically located 200km from Salaverry, which features a port that can service ships with capacities of up to 35,000 tons. The Port of Salaverry provides direct access to the Pacific Ocean.

INFRASTRUCTURE


Water

A river adjacent to the property provides access to water for mining operations. However, most of the coal on the property may be extracted with minimal or no coal washing.

Power
Power lines cut through the property, although Aim is yet to ascertain the capacity of these lines. The company expects to use diesel powered equipment for most of its mining activities.

Roads
The first half of the road from the property to Otuzco is along steep mountainsides and can support 25-ton trucks. The next half of the road to Otuzco is better maintained and can also support 25-ton trucks. The road from Otuzco to the Port of Salaverry is well constructed, paved, and has bridges that can support up to 50-ton loads. This will facilitate smooth hauling of coal to the port.

Besides accessibility to water, transportation and electricity, there are also small villages on the property with ample accommodations and restaurants to service exploration crews and other travelers.

Market Potential

  • Highly desirable resource with a variety of uses. I
  • Primarily used in the manufacturing of steel, the production of cement, and the generation of electricity.
  • 70% of the steel produced globally relies on coal (World Coal Association, 2013); 200kg of coal is required to produce one ton of cement (Van Oss, 2012); and 41% of global electricity production relies on coal (Clemente, 2012).
  • Highest ranking coal because it is older and harder, contains more carbon, has lower moisture content, and burns hotter than any other type of coal. Comprising only 1% of global reserves, anthracite is also the cleanest burning fossil fuel on the planet (Cornerstone, 2013).

Once the joint venture with Prina Energy Aim intends to sell its output to international customers through the joint venture corporation concentrating the marketing efforts in India.

  • Unavailability of Anthracite Coal in India creates a huge potential for coal as a fuel for Indian Steel industry, which is growing on progressive and steady pace.
  • Huge scope for growth is offered by India’s comparatively low per capita steel consumption and the expected rise in consumption due to increased infrastructure construction and the thriving automobile and railways sectors.

Competitive Advantage

Aim has a variety of advantages. The company has a team of technical experts on ground in Peru, and has also recruited advisors and directors who bring complementary skills to the venture. In terms of infrastructure, power lines run through Aim’s property, while a river runs adjacent to the site. The road network from the site to Otuzco can support 25-ton trucks. From Otuzco to Salaverry, the road is paved and well maintained, and can support up to 50-ton trucks. There are also accommodation facilities close to the property that can cater to Aim employees and contractors. Other advantages include competitive labour wages in Peru, and competitive storage and stevedoring costs at the port together with the ability to extract deposits with minimal or no coal washing.

Stock Chart

Durango Receives OK to use Limestone as Fertilizer $DGO.ca

Posted by AGORACOM-JC at 9:50 AM on Wednesday, April 12th, 2017

Logo

  • Management confirms its limestone is suitable for fertilizer use
  • Limestone is extremely beneficial for the agricultural industry including its use as a soil conditioner

Vancouver, BC / April 12, 2017 – Durango Resources Inc. (TSX.V-DGO) (OTC-ATOXF), (the “Company” or “Durango”) announces that further to the news of April 5, 2017 management confirms its limestone is suitable for fertilizer use.

Upon review, it was determined that Durango’s limestone is exempt from the registration process of the Canadian Food Inspection Agency (CFIA). The limestone is still subject to regulations and required to meet all the standards and requirements set forth in the Fertilizers Act and Regulations. Fertilizer and supplement products are regulated under the authority of the Fertilizers Act, which is administered by the CFIA.

Limestone is extremely beneficial for the agricultural industry including its use as a soil conditioner. The limestone is activated when it meets with water and dissolves into the soil, which lowers the acidity and raises the pH, which is essential for crop yields. The lime also adds desirable nutrients to the soils such as calcium, magnesium and phosphorus, which can improve soil structure, increase rates of air and water filtration, improve plant cell wall formation, and help regulate the nutrient uptake through the roots of the plant. Hydroponic-type systems are more prone to incur a calcium deficiency and require the use of limestone.

Marcy Kiesman, CEO of Durango stated, “Durango is fortunate to have highly favourable grades of limestone on the Mayner’s Fortune property. This creates additional opportunities for potential end-users which Durango will now actively investigate commercial-use mediums for its limestone due to the recent CFIA discussions.”

About Mayner’s Fortune

The Mayner’s Fortune property is located 7.5 kilometres southwest of Terrace, B.C., along the CN rail route between Terrace and Kitimat and hosts six historically mapped subparallel limestone units. Durango completed two exploration visits on the Mayner’s Fortune project in the late fall of 2016, which included sampling to test limestone quality and mapping substantiate historic reports. Assays of results of February 8, 2017 and December 14, 2016 achieved CaCO3* (calcium carbonate) (56.00 per cent CaCO (calcium oxide)).

*Theoretical value of CaCO3 is calculated based on the assay value of CaO at 1.78476 per cent and is used to estimate limestone (CaCO3) composition. This calculation assumes all CaO analyzed is present at CaCO3.

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and the NMX East lithium property near the Whabouchi mine and the Buckshot graphite property near the Miller Mine in Quebec, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: durangoresourcesinc@gmail.com

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including, but not limited to the acquisition of additional ground, the entering into of any transaction with any third parties, exploration results on the Mayner’s Fortune Property and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

St-Georges Release More Information on the Thor Gold Project & Arrange Financing $SX.ca

Posted by AGORACOM-JC at 2:55 PM on Tuesday, April 11th, 2017

Sx hub logo

  • Project is part of the recent string of acquisitions by St-Georges
  • Located in the southwest portion of Iceland, about 20 km east of the city center of Reykjavik
  • Conditional to regulatory approval, company is proposing an equity financing of up to $500,000 that could be increased by a 20% over-allocation under certain conditions

Montreal, Quebec / April 11, 2017 – St-Georges Platinum and Base Metals Ltd. (CSE: SX) (OTC: XOOF) (FSE: 85G1) is pleased to present further information on its Thor exploration & development project in Iceland.

Please refer to our March 16, 2017 news release posted on the CSE or our website at www.st-georgesplatinum.com for additional information on location and terms.

Thor Joint-Venture Gold Project

The Thor Project is part of the recent string of acquisitions by St-Georges. The project is located in the southwest portion of Iceland, about 20 km east of the city center of Reykjavik. This area is an active rift zone.

A new internal report completed for St-Georges by Dr. Natasha Henwood, as part of the due diligence process for the acquisition of Iceland Resources, summarizes the previous work programs including the most recent work conducted in 2013. The report includes recommendations to bring the project forward to a resource estimate. St-Georges management is in contact with independent consultants in order to commission a National Instrument 43-101 Technical Report later this spring for the Thor project.

The work Dr. Henwood reviewed confirms the existence of high grade gold values contained in a low sulphidation epithermal system. The mineralized system is comprised of early banded chalcedony-ginguro veins cut by later silica-feldspar veins, and then remobilized faulting with clay gouge and disseminated sulfides.

The previous work program included detailed geologic mapping, petrography, stream sampling and core re-sampling and assaying. Geologic mapping proved difficult because of thick vegetation. Less than 10% of outcrop is available for mapping. Much of the outcrop is limited to ridge tops, cliffs and stream bottoms. The field works in conjunction with structural interpretation from aerial photos have given some limited perspective to geologic and structural controls for mineralization.

A review of past core drilling provided additional important information, Dr. Henwood determined that:

-True thickness on the vein intercepts ranged from 2.2 to 11.4 meters.

-Current length is 560 meters based on drill intercepts (Figure 2).

-Depths of mineralized intervals in core are from surface to 80 meters.

-Gold to silver ratio is approximately 2:1 with some variations.

The work completed on petrology, stream sampling, and core logging and re-assaying provides a strong argument for multiple episodes of gold deposition. Dr. Greg Corbett visited the property in 2004. He postulated plunging, high grade shoots of gold mineralization associated with extensional faulting (Figure 1). His work and drilling conducted on the vein system have shown the vein is open to the north. Stream sampling suggests the vein system may also extend to the south even though drilling appears to cut it off.

The core resampling program indicated substantial repeatability of higher grades of gold. However, no resamples were conducted on low and moderate grade samples in 2013. Historic sampling of the low and moderate grades was generally less than 10% difference. This problem will likely require twinning of past high grade drill holes with larger core.

Figure 1: Structural model for Iceland (Corbett 2004)


Click Image To View Full Size

The poor repeatability of the higher grade samples can be attributed to nugget effect and the current condition of the available core. Much of the resampling (12 of 15 samples) exceeded a 10% difference between the original 2006 sampling and the 2013 sampling. Eight of the samples measured significantly higher (24% to 286%) while 3 were significantly lower (-27% to -42%). Table 1 below shows the results of the sampling of best grades correlation of resampling of these intervals.

Table 1 – Results showing 2006 assays and 2013 re-assay

 


Click Image To View Full Size

 

Figure 2: Plan map of Thor project with drilling and vein intercepts.
Click Image To View Full Size

Past work along with Dr. Henwood’s summary analysis provides an excellent framework for St. Georges upcoming work programs. The company is determining the best geophysical methods to test for extensions of the known mineralization along strike and at depth. A drill program will then be permitted to test the results. The drilling will target specific high grade gold shoots based on past drilling and Dr. Corbett’s model. Deeper drilling will assess the gold encountered at depths of 420 meters with the goal of identifying additional high grade resources.

Financing

Management has been approached by different parties to finance the company. Conditional to regulatory approval the Company is proposing an equity financing of up to $500,000 that could be increased by a 20% over-allocation under certain conditions.

Terms

$0.03 per unit. Each unit includes one common share and one unit special warrant. Each unit’s special warrant will have an execution price of $0.06 and an 18 months life span. When executed the special unit warrants will enable the warrant holder to acquire one common share and one standard warrant. The standard warrant will be valid for 18 month concurrently to the special warrant and bear an execution price of $0.12. This warrant will allow the holder to receive one common share. All securities issued under this financing will be restricted from resale for 4 months.

If all warrants are executed, the holder of the units would have acquired 3 common shares for each unit subscribed at an average of $0.07 per share.

Related Parties Participation

Insiders and related parties, including geological contractors in Iceland may decide to participate in this financing. Insiders and related parties will participate on the basis of a voluntary 18 months restriction on the common share subscribed.

Multilateral Instrument 61-101

Given the proposed participation of the insider holders, the proposed financing constitutes a “related party transaction” within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security holders in Special Transactions (“MI 61-101″).

St-Georges is relying on an exemption to both the formal valuation and the minority shareholder approval requirements of MI 61-101, as neither the fair market value of the Units to be distributed to, nor the fair market value of the consideration to be received by St-Georges from the insider holders in connection with the proposed financing exceeds 25% of St-Georges’ share capitalisation.

The technical information in this release has been reviewed and approved by Mr. Herb Duerr, P. Geo. a ‘qualified person’ as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects.

ON BEHALF OF THE BOARD OF DIRECTORS

“Frank Dumas

FRANK DUMAS, PRESIDENT & CEO

About St-Georges

St-Georges is developing new technologies to solve the biggest environmental problems in the mining industry. If these new technologies are successful, they should improve the financial bottom line of current mining producers. The potential success of these technologies would also involve upgrading certain current known metal resources to economic status while addressing the environmental and social acceptability issues.

The Company control directly or indirectly all of the active mineral tenures in Iceland. It also explores for Nickel on the Julie Nickel Project & for industrial minerals on the Quebec’s North Shore and for Lithium and rare metals in Northern Quebec and in the Abitibi area. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1. For additional information, please visit our website at www.st-georgesplatinum.com

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.